US 8293724
Therapeutic applications of fatty acid amide hydrolase inhibitors
granted A61PA61P25/22A61P25/24
Quick answer
US patent 8293724 (Therapeutic applications of fatty acid amide hydrolase inhibitors) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Oct 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61P, A61P25/22, A61P25/24, A61P27/06, A61P9/12